Dendritic cells in atherosclerotic plaques: Solving identification puzzles

Pathology

Volumn 43, Issue 7, 2011, Pages 760-764

  Van Vré, Emily A ^a   Bult, Hidde ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84858171660     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e32834d3601     Document Type: Letter

References (22)

1. Van Vré EA, Van Brussel I, Maris M, et al. Immunohistochemical characterisation of dendritic cells in human atherosclerotic lesions: possible pitfalls. Pathology 2011; 43: 239-47.
2. Pistulli R., Yilmaz A., Immunohistochemical characterisation of vascular dendritic cells: puzzling the pitfalls. Pathology 2011; 43: 764-7.
3. Hashimoto Y, Kim DJ, Adams JC. The roles offascins in health and disease. J Pathol 2011; 224: 289-300.
4. Jayo A, Parsons M. Fascin: a key regulator of cytoskeletal dynamics. Int J Biochem Cell Biol 2010; 42: 1614-7.
5. Goncharuk VN, Ross JS, Carlson JA. Actin-binding protein fascin expression in skin neoplasia. J Cutan Pathol 2002; 29: 430-8.
6. Zhang FR, Tao LH, Shen ZY, Lv Z, Xu LY, Li EM. Fascin expression in human embryonic, fetal, and normal adult tissue. J Histochem Cytochem 2008; 56: 193-9. (Pubitemid 351170971)
7. Quintavalle M, Elia L, Condorelli G, Courtneidge SA. MicroRNA control of podosome formation invascular smooth muscle cells invivo and in vitro. J Cell Biol 2010; 189: 13-22.
8. Kockx MM, Cromheeke KM, Knaapen MW, et al. Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler Thromb Vasc Biol 2003; 23: 440-6. (Pubitemid 36337220)
9. De Meyer GRY, Hoylaerts MF, Kockx MM, Yamamoto H, Herman AG, Bult H. Intimal deposition of functional von Willebrand factor in ather-ogenesis. Arterioscler Thromb Vasc Biol 1999; 19: 2524-34. (Pubitemid 29477855)
10. Bobryshev YV, Lord RS. 55-kD actin-bundling protein (p55) is a specific marker for identifying vascular dendritic cells. J Histochem Cytochem 1999; 47: 1481-6.
11. Yilmaz A, Lochno M, Traeg F, et al. Emergence of dendritic cells in ruptureprone regions of vulnerable carotid plaques. Atherosclerosis 2004; 176: 101-10. (Pubitemid 39078651)
12. Kawahara I, Kitagawa N, Tsutsumi K, Nagata I, Hayashi T, Koji T. The expression of vascular dendritic cells in human atherosclerotic carotid plaques. Hum Pathol 2007; 38: 1378-85. (Pubitemid 47247481)
13. Korpelainen EI, Gamble JR, Vadas MA, Lopez AF. IL-3 receptor expression, regulation and function in cells of the vasculature. Immunol Cell Biol 1996; 74: 1-7. (Pubitemid 26150497)
14. Frendl G. Interleukin 3: from colony-stimulating factor to pluri-potent immunoregulatory cytokine. Int J Immunopharmacol 1992; 14: 421-30.
15. Burdach S, Nishinakamura R, Dirksen U, Murray R. The physiologic role of interleukin-3, interleukin-5, granulocyte-macrophage colony-stimulating factor, and the beta c receptor system. Curr Opin Hematol 1998; 5: 177-80. (Pubitemid 28360542)
16. Erbel C, Sato K, Meyer FB, et al. Functional profile of activated dendritic cells in unstable atherosclerotic plaque. Basic Res Cardiol 2007; 102: 123-32. (Pubitemid 46189953)
17. Zhou LJ, Schwarting R, Smith HM, Tedder TF. A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J Immunol 1992; 149: 735-42.
18. Breloer M, Fleischer B. CD83 regulates lymphocyte maturation, activation and homeostasis. Trends Immunol 2008; 29: 186-94.
19. Hoymans VY, Bosmans JM, Ursi D, et al. Immunohistostaining assays for detection of Chlamydia pneumoniae in atherosclerotic arteries indicate cross-reactions with nonchlamydial plaque constituents. J Clin Microbiol 2004; 42: 3219-24. (Pubitemid 38938083)
20. Cromheeke KM, Kockx MM, De Meyer GRY, et al. Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques. Cardiovasc Res 1999; 43: 744-54. (Pubitemid 29369273)
21. Dzionek A, Fuchs A, Schmidt P, et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000; 165: 6037-46.
22. Van Brussel I, Van Vré EA, De Meyer GRY, Vrints CJ, Bosmans JM, Bult H. Expression of dendritic cell markers CD11c/BDCA-1 and CD123/BDCA-2 in coronary artery disease upon activation in whole blood. J Immunol Methods 2010; 362: 168-75.